openPR Logo
Press release

U.S Biosimilars Market: Abbvie's Humira to face new biosimilar competition in U.S.

12-07-2022 11:39 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
U.S Biosimilars Market: Abbvie's Humira to face new biosimilar

The global biosimilars industry was estimated at $15.9 billion in 2021, and is anticipated to hit $143.6 billion by 2031, registering a CAGR of 24.7% from 2022 to 2031.

Download Sample PDF at:

https://www.alliedmarketresearch.com/request-sample/162

Covid-19 scenario-

The COVID-19 pandemic created difficulties for the pharmaceutical industry to focus on R&D activities including biosimilar development, which impacted the global biosimilars market negatively.

Moreover, there was a delay in product approvals and product launches, owing to the global health crisis, which further restricted the expansion of the market.

Specific Requirement on COVID-19? Ask to Our Industry Expert:

https://www.alliedmarketresearch.com/request-for-customization/162?reqfor=covid

Europe garnered the major share in 2021-

Based on region, Europe held the major share in 2021, generating nearly two-fifths of the global biosimilars market. At the same time, the same region would also grow at the fastest CAGR of 25.9% by 2031. This is attributed to rise in the prevalence of cancer and increase in launches of multiple biosimilars in the region.

Key players in the industry-

Exxon Mobil Corporation
Haihang Industry Co., Ltd.
Kent elastomer products
Kuraray Co.
Shell,Ltd.
SIBUR
Dupont
The Goodyear Tire & Rubber Company

Speak to our Analysts:

https://www.alliedmarketresearch.com/connect-to-analyst/162

Important Questions Being Answered by the Market Report

What is the Biosimilars Market size and growth?

What are the prominent and latest trends impacting the market?

Which regions will observe growth on new occasions?

Which players are adopting a functioning and planned framework to obtain customer loyalty?

Request Customization:

https://www.alliedmarketresearch.com/request-for-customization/162

Contact
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S Biosimilars Market: Abbvie's Humira to face new biosimilar competition in U.S. here

News-ID: 2838275 • Views:

More Releases from Allied Market Research

Mortar Ammunition Market Demand, Growth Opportunities, Analysis by Top Key Playe …
Mortar ammunitions are stealth, robust and modern devices that can launch to a counter at short and low nearing activities. Modern-age mortars are light in weight and portable in nature. These ammunitions generally come in two types: fin-stabilized and spin-stabilized. Fin-Stabilized projectiles obtain stability through use of fins located at the aft of projectile. Spin-stabilized projectile technology has been used for aerodynamic stabilization. Glided path is auto-tracked and spinning creates
Orthodontic Headgear Market is Projected to Reach $2,094.00 Million by 2031, Growing at a CAGR of 5.4%
Orthodontic Headgear Market is Projected to Reach $2,094.00 Million by 2031, Gro …
The Orthodontic Headgear Market is a dynamic and integral segment of the orthodontic industry, playing a pivotal role in the correction of malocclusions and the alignment of teeth. Orthodontic headgear is a crucial orthodontic appliance used to address a wide range of dental and skeletal irregularities, such as overbites, underbites, and spacing issues. This market is witnessing substantial growth as orthodontic treatments become increasingly popular for both functional and cosmetic
Olive Oil Market Analysis, Size, Growth, Trends, Segmentation, Opportunity and Forecast to 2032
Olive Oil Market Analysis, Size, Growth, Trends, Segmentation, Opportunity and F …
The global olive oil industry was valued at $18,552.6 million in 2022, and is projected to reach $30,196.4 million by 2032, registering a CAGR of 5.2% from 2023 to 2032. The olive oil market has experienced significant growth driven by several prime determinants. The increase in awareness and adoption of healthier lifestyles have led consumers to seek alternatives to traditional cooking oils, with olive oil being recognized for its numerous health
Hotel Toiletries Market Revenue is expected to Surpass $50.5 billion by 2031
Hotel Toiletries Market Revenue is expected to Surpass $50.5 billion by 2031
The hotel toiletries market was valued at $17.9 billion in 2021, and is estimated to reach $50.5 billion by 2031, growing at a CAGR of 10.8% from 2022 to 2031. Get Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/75060 There is a greater demand for hotel toiletries with the growth of the tourism industry and the rise in international travel. Improved transportation, economic growth, globalization, technology advancements, and other initiatives have

All 5 Releases


More Releases for Biosimilars

Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Biosimilars Market Size During the Forecast Period? The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth? The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million